Research & Development



  “她為什麼要這麼做呢?”   尤其是在他看到阿嬌的賬簿之後,這種感覺就越發的強烈了,一個皇帝還沒有自己一個下堂婦有錢,這讓他對自己的皇帝身份產生了前所未有的懷疑。彩票开奖查询1919期   狗子從自己的背包里找出一個黑肚子瓷瓶遞給霍光道︰“有糖霜。”宝马彩票app下载送38   雲瑯咬牙切齒的道︰“請皇後陛下在派人管束皇長子的同時,不妨連劣徒一起管束一下。”   張安世還想多問,見先生開始看章程了,就閉上嘴巴,立刻離開雲氏莊園去了長安。038彩票安卓大厅   進入醫者狀態的甦稚完全沒有了公孫敖以為的妖艷感,此時的甦稚語氣不急不緩,話語中有一種讓人不容置疑的權威感,讓人不得不相信,她說的話都是真的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo